FIELD: biotechnology.
SUBSTANCE: what is presented is the Lactobacillus reuteri VKM B-3734D strain possessing Helicobacter pylori antagonist action. Strain is non-toxic for mammalian cells.
EFFECT: invention enables to use the disclosed strain for producing probiotics and metabiotics.
2 cl, 1 dwg, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METABIOTIC COMPOSITION BASED ON LACTOBACILLUS REUTERI AND BACILLUS SUBTILIS | 2023 |
|
RU2835358C2 |
| METHOD FOR MONOTHERAPY OF GASTRITIS ASSOCIATED WITH HELICOBACTER PYLORI INFECTION | 2020 |
|
RU2758246C1 |
| REUTERIN-PRODUCING LACTOBACILLUS BREVIS | 2011 |
|
RU2577994C1 |
| METABIOTIC COMPOSITION WITH SORBENT PROPERTIES AND METHOD FOR PREPARATION THEREOF | 2023 |
|
RU2833932C2 |
| METHOD OF DIAGNOSTIC OF THE STATE OF INTESTINES MICROBIOTIC ON THE BACKGROUND OF ERADICATION THERAPY Helicobacter pylori AND ITS APPLICATION | 2015 |
|
RU2616280C1 |
| METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
| METHOD OF STUDY OF GASTRIC AND INTESTINAL MICROBIOTA DURING SUPPRESSION OF COLONIZATION RESISTANCE OF GASTRIC MUCOSA OF EXPERIMENTAL ANIMALS | 2019 |
|
RU2745654C1 |
| LIQUID SYMBIOTIC AND METHOD FOR OBTAINING IT | 2022 |
|
RU2805957C1 |
| METHOD FOR ERADICATION OF HELICOBACTER PYLORI BACTERIA IN EXPERIMENTAL HELICOBACTERIOSIS IN CONVENTIONAL WHITE MICE AND A MEANS FOR ITS IMPLEMENTATION | 2020 |
|
RU2746590C1 |
| PHARMACEUTICAL COMPOSITION OF PROTON PUMP INHIBITOR AND PREBIOTIC FOR TREATING GASTRIC AND DUODENAL ULCERS | 2009 |
|
RU2410100C2 |
